The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and survival among patients with extensive disease small cell lung cancer (ED-SCLC).
 
Mark D. Danese
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Grail (Inst); Janssen (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst)
Research Funding - Allergan (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Grail (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst)
 
Michelle L. Gleeson
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
 
Deborah P. Lubeck
Employment - Outcomes Insights
Stock and Other Ownership Interests - Amgen
Consulting or Advisory Role - Bristol-Myers Squibb
 
Beata Korytowsky
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sarah Bobiak
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I)